Omnio
Umeå, Sweden · Biotechnology, Health Care, Medical
Omnio is a Umeå-based BioTech startup developing plasminogen-based therapies for chronic wounds and related conditions. Founded on research by Professor Tor Ny, the company is focused on addressing impaired wound healing, particularly in diabetic foot ulcers. Its lead drug candidate is a recombinant form of plasminogen aimed at helping patients regain mobility and avoid amputation. The company is
Key facts
- Headquarters
- Umeå, Sweden
- Employees
- 51
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- omnio.com
- Company page
Recent activity at Omnio
Omnio funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2026 | Seed | $2.9M |
Omnio in the news
- Spanner Omni, now GA: A distributed, multi-model database that you can deploy anywhere - Google Cloud (Sep 30, 2026)
- ICE Deportation Flights Are Getting Longer and Crueler - Mother Jones (Jan 30, 2026)
- Google debuts new AI models, personal AI agents in effort to keep pace with OpenAI and Anthropic - CNBC (May 19, 2026)
- The Steelseries Arctis Nova Pro Omni Is One of the Best Headsets for Multisystem Gamers - WIRED (Jul 31, 2026)
- Gemini Omni is Google's new world model, with advanced AI video generation capabilities - Mashable (May 19, 2026)
- Forever Young - University of Pennsylvania (Dec 01, 2025)
- Google’s Gemini Omni turns images, audio, and text into video — and that’s just the start - TechCrunch (May 19, 2026)
- Cybersecurity expert shares what guests, hotels should know in wake of Omni breach - ABC News - Breaking News, Latest News and Videos (Feb 15, 2026)
Companies similar to Omnio
- Scipher Medicine · Biotechnology, Health Care, Medical, Therapeutics
- N-Power Medicine · Biotechnology, Health Care, Medical, Therapeutics
- Novadip Biosciences · Biotechnology, Health Care, Medical, Therapeutics
- Nanoscope Therapeutics · Biotechnology, Health Care, Medical, Therapeutics
- Grey Wolf Therapeutics · Biotechnology, Health Care, Medical, Therapeutics
About Omnio: questions and answers
What does Omnio do?
Omnio is a Umeå-based BioTech startup developing plasminogen-based therapies for chronic wounds and related conditions. Founded on research by Professor Tor Ny, the company is focused on addressing impaired wound healing, particularly in diabetic foot ulcers. Its lead drug candidate is a recombinant form of plasminogen aimed at helping patients regain mobility and avoid amputation. The company is
Where is Omnio headquartered?
Omnio is headquartered in Umeå, Sweden.
How many employees does Omnio have?
Omnio has about 51 employees.
Has Omnio raised funding?
Yes. Fundz has recorded 1 funding event for Omnio. The most recent, Seed of $2.9M, was in Oct 2026.
What is the latest news on Omnio?
On Oct 02, 2026, Omnio raises €2.9 million to advance its plasminogen-based therapy for chronic wounds. This funding round was oversubscribed and led by existing investors.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy